Avadomide (CC-122)
目录号: A16854
E3 Ligase 抑制剂
Avadomide(CC-122),一种被称为多效途径修饰剂的新化学实体,是一种针对弥漫大B细胞淋巴瘤(DLBCL)的新型药物,具有抗肿瘤和免疫调节活性。其分子靶点是蛋白质cereblon(CRBN),是cullin环E3泛素连接酶复合体CRL4CRBN的底物受体。
| Discription | Avadomide(CC-122), a new chemical entity termed pleiotropic pathway modifier, is a novel agent for Diffuse large B-cell lymphoma(DLBCL) with antitumor and immunomodulatory activity. Its molecular target is the protein cereblon (CRBN), a substrate receptor of the cullin ring E3 ubiquitin ligase complex CRL4CRBN. |
|---|
| 目录号 | A16854 |
|---|---|
| 分子式 | C14H14N4O3 |
| 分子量 | 286.29 |
| CAS号 | 1015474-32-4 |
| SMILES | O=C(C(N1C(C)=NC2=C(C(N)=CC=C2)C1=O)CC3)NC3=O |
| 其他名称 | CC122, CC 122 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | 50 mg/mL (174.64 mM) | |
| Water | Insoluble | ||
| Ethanol | <1 mg/mL | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 34.93 mL | 174.65 mL | 349.3 mL |
| 0.5 mM | 6.99 mL | 34.93 mL | 69.86 mL |
| 1 mM | 3.49 mL | 17.46 mL | 34.93 mL |
| 5 mM | 0.7 mL | 3.49 mL | 6.99 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2